Gyros Protein Technologies

🚀 Are you attending #TIDES2024 in Hamburg, Germany, November 11-14? Let’s connect at booth #316! Our experts, Cátia Teixeira and Luísa Aguiar, are excited to share how our PurePep solutions can elevate your peptide projects to the next level. 💡 The peptide therapeutics landscape is rapidly evolving, driven by two major trends: ⭐ Innovative Screening Platforms: Chemical and display screening platforms are becoming the new standard for target-based drug development, enriching the preclinical pipeline significantly. ⭐ GLP-1 Analogs Success: The breakthrough in GLP-1 analogs for weight loss and obesity is transforming pharmaceutical interest in peptides, leading to high demand and a capacity crunch in synthesis. We’re here to help you navigate these changes—see you in Hamburg! #purepep #forpeptidescientists #synthesis #purification

⏳ There is still time to register for tomorrow's webinar: New Assay for Antibody Kinetic Analysis! Hear Eric Janezic, Principal Scientist at Genentech present the development of a novel assay to calculate the kinetic binding parameters of up to 30 antibodies simultaneously to living cells. This breakthrough approach addresses the challenges of traditional methods, providing real-time kinetic data without lengthy incubation or labeling. Discover: ✅ The limitations of current pre-equilibrium methods. ✅ How our new assay efficiently determines ka, kd, and KD of unlabeled antibodies. ✅ Ways automated microfluidics can accelerate the selection of lead candidates. 🗓️ October 31 Title: Overcoming challenges in determining antibody binding rate constants on cells: a new assay on the horizon? Speakers: 🗣️ Eric Janezic, Principal Scientist, Genentech (CA, USA) 🗣️ Jasmine Singh, Application Scientist, Gyros Protein Technologies (Uppsala, Sweden) Don't miss this opportunity to learn how to enhance your drug discovery process! Register now! https://lnkd.in/dgkwtJXJ #AntibodyKinetics #DrugDiscovery #Bioanalysis #GyrolabTechnology #Automation

Are you involved in the development of monoclonal antibody-based therapeutics? Then you do not want to miss our insightful webinar in collaboration with Gyros Protein Technologies: Overcoming challenges in determining antibody binding rate constants on cells: a new assay on the horizon? Can’t make the live date on Thursday 31 October? No need to worry! Register now and watch the webinar on demand! >>> https://hubs.ly/Q02QWxWp0

Exciting Opportunity for a Mechanical Engineer at Gyros Protein Technologies in Uppsala! Are you a talented Mechanical Engineer looking to make a meaningful impact in the biotech industry? Gyros Protein Technologies is seeking a passionate individual to join our innovative team in Uppsala. Learn more and apply today: https://lnkd.in/ddipaQkp

🔔 One Day Left at ESGCT in Rome! It’s been an incredible event so far, and we want to thank everyone who stopped by our booth and engaged with us! 🙌 But the event isn’t over yet. If you haven’t had a chance to connect with us, we’re still here at Booth #D21 for one more day. 👥 We had some fantastic discussions after our poster presentation "Development of a novel nanoliter scale total antibody (TAb) assay to detect pre-existing antibodies against AAV vectors regardless of serotype.", and we’re eager to keep the conversation going. If you missed the session or want to dive deeper into the topic, come by the booth! Let’s talk about how Gyrolab® technology can accelerate your AAV-based research and make your workflows more efficient. 💡 See you at Booth D21! 🚀 #ESGCT #GeneTherapy #Gyrolab #Biopharma #Immunoassay #AAVResearch

Join us at ESGCT in Rome this week. Stop by booth #D21 and chat with the Gyros Protein Technologies team, Joris Venet. Francesco Vitrani and Kira Hedström to discover how we could help accelerate your bioanalysis work. 📣 Kira Hedström will present a poster "Development of a novel nanoliter scale total antibody (TAb) assay to detect pre-existing antibodies against AAV vectors regardless of serotype." 👀 Hope to see you at booth #D21! #ESGCT2024 #AAVvectors #immunoassys

New webinar on a novel high-throughput determination of antibody-receptor interaction using live cells. Register to attend! This technique was also described in the below 2023 publication: Janezic, EM et al. (2024). A novel, label-free, pre-equilibrium assay to determine the association and dissociation rate constants of therapeutic antibodies on living cells. British Journal of Pharmacology, 181(20), 3836–3855. https://lnkd.in/g4KjFbbC

Second day at the 19th Annual Peptide Therapeutics Symposium at the beautiful Scripps Seaside Forum in San Diego. If you're attending and want to discuss the latest in peptide innovation or simply connect, make sure to find Derek Gonzales—he is ready to meet you there! During today’s breaks, he will be presenting his poster on ‘Greener Synthesis and Purification Solutions in the New Era of Peptide Therapeutics.’ 🌱 This is an exciting opportunity to explore sustainable advancements in peptide development and engage in discussions on the latest trends shaping the field." #purepep #forpeptidescientists #synthesis #purification

📣 Are you attending the 19th Annual Peptide Therapeutics Symposium at the Scripps Seaside Forum in San Diego? 🔬 If you're attending and want to explore the latest in peptide innovation or simply connect, be sure to find Derek Gonzales—he’d love to meet you there! #purepep #forpeptidescientists #synthesis #purification

Discover Boehringer Ingelheim's Strategy for Fast and Robust HCP Analysis Boehringer Ingelheim’s Martin Voigtmann reveals their approach to HCP monitoring. Discover strategies for improved process insights and faster screening in our on-demand webinar! https://hubs.ly/Q02TWSp90 #OnDemandWebinar #Gyrolab #HCP #Bioprocess